Licensed vaccine
Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
FDA-licensed vaccine · STN BL 125296
Key facts
| Proper name | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
|---|---|
| Submission tracking number (STN) | BL 125296 |
| FDA product areas | Biologics, Vaccines |
| Recent FDA documents | October 15, 2019 Approval Letter - Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Approval History, Letters, Reviews and Related Documents - Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Package Insert - Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Supporting Documents older than three years - Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
| FDA page updated | Oct 15, 2019 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: